, ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur Heart J, vol.35, p.2733, 2014.

B. J. Maron, J. M. Gardin, J. M. Flack, S. S. Gidding, T. T. Kurosaki et al., Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the CARDIA Study, Circulation, vol.92, p.785, 1995.

C. Semsarian, J. Ingles, M. S. Maron, and B. J. Maron, New perspectives on the prevalence of hypertrophic cardiomyopathy, J Am Coll Cardiol, vol.65, issue.12, pp.1249-1254, 2015.

E. Biagini, C. Pazzi, I. Olivotto, B. Musumeci, G. Limongelli et al., Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy, Am J Cardiol, vol.118, p.432, 2016.

D. D. Savage, S. F. Seides, C. E. Clark, W. L. Henry, B. J. Maron et al., Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy, Circulation, vol.58, issue.3, pp.402-410, 1978.

P. N. Casale, R. B. Devereux, P. Kligfield, R. R. Eisenberg, D. H. Miller et al., Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria, J Am Coll Cardiol, vol.6, issue.3, pp.572-80, 1985.

T. Konno, Y. Nagata, R. Teramoto, N. Fujino, A. Nomura et al., Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy, Am J Cardiol, vol.117, issue.3, pp.443-452, 2016.

C. J. Mcleod, M. J. Ackerman, R. A. Nishimura, A. J. Tajik, B. J. Gersh et al., Outcome of Patients with Hypertrophic Cardiomyopathy and a Normal Electrocardiogram, J Am Coll Cardiol, vol.54, p.229, 2009.

B. J. Maron, J. K. Wolfson, E. Ciró, and P. Spirito, Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy, Am J Cardiol, vol.51, p.189, 1983.

M. Sabater-molina, I. Pérez-sánchez, H. Del-rincón, J. P. Gimeno, and J. R. , Genetics of hypertrophic cardiomyopathy: A review of current state, Clin Genet, vol.93, issue.1, pp.3-14, 2018.

A. J. Marian, Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy, Lancet, vol.355, issue.9197, pp.58-60, 2000.

M. J. Davies and W. J. Mckenna, Hypertrophic cardiomyopathy pathology and pathogenesis, Histopathology, vol.26, issue.6, pp.493-500, 1995.

M. A. Burke, S. A. Cook, J. G. Seidman, and C. E. Seidman, Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy, J Am Coll Cardiol, vol.68, issue.25, pp.2871-2886, 2016.

P. Elliott, J. R-gimeno, R. Thaman, . Shah, . Ward et al., Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy, Heart, vol.92, issue.6, pp.785-791, 2006.

P. Spirito, P. Bellone, K. M. Harris, P. Bernabo, P. Bruzzi et al., Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy, N Engl J Med, vol.342, issue.24, pp.1778-85, 2000.

M. S. Maron, I. Olivotto, S. Betocchi, S. A. Casey, J. R. Lesser et al., Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy, N Engl J Med, vol.348, issue.4, pp.295-303, 2003.

P. M. Elliott, J. R. Gimeno, M. T. Tomé, J. Shah, D. Ward et al., Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy, Eur Heart J, vol.27, issue.16, pp.1933-1974, 2006.

M. S. Maron, I. Olivotto, A. G. Zenovich, M. S. Link, N. G. Pandian et al., Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction, Circulation, vol.114, pp.2232-2239, 2006.

L. Monserrat, P. M. Elliott, J. R. Gimeno, S. Sharma, M. Penas-lado et al., Non sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients, J Am Coll Cardiol, vol.42, issue.5, pp.873-882, 2003.

P. Spirito, C. Autore, C. Rapezzi, P. Bernabò, R. Badagliacca et al., Syncope and risk of sudden death in hypertrophic cardiomyopathy, Circulation, vol.119, issue.13, pp.1703-1713, 2009.

C. O'mahony, F. Jichi, M. Pavlou, L. Monserrat, A. Anastasakis et al., A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD), Eur Heart J, vol.35, 2010.

P. Melacini, C. Basso, A. Angelini, C. Calore, F. Bobbo et al., Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy, Eur Heart J, vol.31, issue.17, pp.2111-2123, 2010.

Y. Xiao, K. Q. Yang, Y. K. Yang, Y. X. Liu, T. Tian et al., Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy, Chin Med J (Engl), vol.128, issue.11, pp.1483-1492, 2015.

M. S. Maron, B. M. Kalsmith, J. E. Udelson, W. Li, and D. Denofrio, Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy. Circ Heart Fail, vol.3, pp.574-583, 2010.

K. Vaidya, C. Semsarian, and K. H. Chan, Atrial Fibrillation in Hypertrophic Cardiomyopathy, Heart Lung Circ, vol.26, issue.9, pp.975-982, 2017.

P. A. Vriesendorp, M. Liebregts, R. C. Steggerda, A. F. Schinkel, R. Willems et al., Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy, JACC Heart Fail, vol.2, issue.6, pp.630-636, 2014.

A. P. Landstrom and M. J. Ackerman, Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy, Circulation, vol.122, issue.23, pp.2441-2450, 2010.

M. Kelly and C. Semsarian, Multiple mutations in genetic cardiovascular disease: a marker of disease severity? Circ Cardiovasc Genet, vol.2, pp.182-90, 2009.

M. J. Ackerman, S. L. Vandriest, S. R. Ommen, M. L. Will, R. A. Nishimura et al., Prevalence and age-dependence of malignant mutations in the betamyosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective, J Am Coll Cardiol, vol.39, issue.12, pp.2042-2050, 2002.

J. Moolman, V. A. Corfield, B. Posen, K. Ngumbela, C. Seidman et al., Sudden death due to troponin T mutations, J Am Coll Cardiol, vol.29, issue.3, pp.549-55, 1997.

E. W. Hancock, B. J. Deal, D. M. Mirvis, P. Okin, P. Kligfield et al., AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy: A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology, Circulation, vol.119, p.25131, 2009.

P. M. Rautaharju, B. Surawicz, and L. S. Gettes, AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part IV, J Am Coll Cardiol, vol.53, p.982, 2009.

B. Surawicz, R. Childers, B. J. Deal, and L. S. Gettes, AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part III, J Am Coll Cardiol, vol.53, p.976, 2009.

J. M. Gardin, D. B. Adams, and P. S. Douglas, Recommendations for a standardized report for adult transthoracic echocardiography: A report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report, Journal of the American Society of Echocardiography, vol.15, issue.3, pp.275-290, 2002.

S. Bongioanni, F. Bianchi, A. Migliardi, R. Gnavi, P. G. Pron et al., Relation of QRS Duration to Mortality in a Community-Based Cohort with Hypertrophic Cardiomyopathy, Am J Cardiol, vol.100, p.503, 2007.

M. Das and D. P. Zipes, Fragmented QRS: a predictor of mortality and sudden cardiac death. Heart Rhythm, vol.6, pp.8-14, 2009.

K. W. Kang, A. H. Janardhan, K. T. Jung, H. S. Lee, M. H. Lee et al., Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy, Heart Rhythm, 2014.

T. Konno, K. Hayashi, N. Fujino, R. Oka, A. Nomura et al., Electrocardiographic QRS Fragmentation as a Marker for Myocardial Fibrosis in Hypertrophic Cardiomyopathy, J Cardiovasc Electrophysiol, vol.26, issue.10, pp.1081-1088, 2015.

J. N. Johnson, C. Grifoni, J. M. Bos, M. Saber-ayad, S. R. Ommen et al., Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy, Eur Heart J, vol.32, issue.9, pp.1114-1134, 2011.

B. Gray, J. Ingles, C. Medi, and C. Semsarian, Prolongation of the QTc interval predicts appropriate implantable cardioverter-defibrillator therapies in hypertrophic cardiomyopathy, JACC Heart Fail, vol.1, issue.2, pp.149-55, 2013.

Y. Li, J wave is associated with increased risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy, J Int Med Res, 2013.

C. Antzelevitch, S. Gan-xin-yan, and . Viskin, Rationale for the Use of the Terms J Wave Syndromes and Early Repolarization, J Am Coll Cardiol, vol.57, issue.15, pp.1587-1590, 2011.

M. Haïssaguerre, N. Derval, F. Sacher, L. Jesel, I. Deisenhofer et al., Sudden cardiac arrest associated with early repolarization, N Engl J Med, vol.358, pp.2016-2039, 2008.

G. X. Yan and C. Antzelevitch, Cellular basis for the electrocardiographic J wave, Circulation, vol.93, issue.2, pp.372-381, 1996.

T. Tsuda, K. Hayashi, T. Konno, K. Sakata, T. Fujita et al., J Waves for Predicting Cardiac Events in Hypertrophic Cardiomyopathy, JACC Clin Electrophysiol, vol.3, issue.10, pp.1136-1142, 2017.

K. Tuluce, Y. Tuluce, S. , K. Eren, N. Kocabas et al., Predictors of Future Atrial Fibrillation Development in Patients with Hypertrophic Cardiomyopathy: A Prospective Follow-Up Study, Echocardiography, vol.33, issue.3, pp.379-85, 2016.

J. B. Nielsen, C. Graff, A. Pietersen, B. Lind, J. J. Struijk et al., J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG study, J Am Coll Cardiol, vol.61, issue.25, pp.2557-64, 2013.

S. D. Delcrè, D. Donna, P. Leuzzi, S. Miceli, S. Bisi et al., Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study, Int J Cardiol, vol.167, issue.3, pp.1038-1083, 2013.

E. Passini, A. Mincholé, R. Coppini, E. Cerbai, B. Rodriguez et al., Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy, J Mol Cell Cardiol, vol.96, pp.72-81, 2016.

G. F. Tomaselli, D. J. Beuckelmann, H. G. Calkins, R. D. Berger, P. D. Kessler et al., Sudden cardiac death in heart failure. The role of abnormal repolarization, Circulation, vol.90, issue.5, pp.2534-2543, 1994.

B. J. Maron, I. Olivotto, P. Spirito, S. A. Casey, P. Bellone et al., Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referralbased patient population, Circulation, vol.102, p.858, 2000.

M. P. Vergé, H. Cochet, A. Reynaud, L. Morlon, J. Peyrou et al., Characterization of hypertrophic cardiomyopathy according to global, regional, and multi-layer longitudinal strain analysis, and prediction of sudden cardiac death, Int J Cardiovasc Imaging, vol.34, issue.7, pp.1091-1098, 2018.

I. Olivotto, F. Cecchi, C. Poggesi, and M. H. Yacoub, Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail, vol.5, pp.535-581, 2012.

J. Ashok, M. Shah, P. Hocini, L. Pascale, Y. Roten et al., Body Surface Electrocardiographic Mapping for Non-invasive Identification of Arrhythmic Sources, Arrhythm Electrophysiol Rev, vol.2, issue.1, pp.16-22, 2013.